Your browser doesn't support javascript.
loading
Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemia.
Hashimoto, Mari; Saito, Yoriko; Nakagawa, Ryo; Ogahara, Ikuko; Takagi, Shinsuke; Takata, Sadaaki; Amitani, Hanae; Endo, Mikiko; Yuki, Hitomi; Ramilowski, Jordan A; Severin, Jessica; Manabe, Ri-Ichiroh; Watanabe, Takashi; Ozaki, Kokoro; Kaneko, Akiko; Kajita, Hiroshi; Fujiki, Saera; Sato, Kaori; Honma, Teruki; Uchida, Naoyuki; Fukami, Takehiro; Okazaki, Yasushi; Ohara, Osamu; Shultz, Leonard D; Yamada, Makoto; Taniguchi, Shuichi; Vyas, Paresh; de Hoon, Michiel; Momozawa, Yukihide; Ishikawa, Fumihiko.
Afiliação
  • Hashimoto M; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Saito Y; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Nakagawa R; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Ogahara I; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Takagi S; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
  • Takata S; Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Amitani H; Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Endo M; Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Yuki H; Laboratory for Structure-Based Molecular Design, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.
  • Ramilowski JA; Laboratory for Applied Computational Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Severin J; Laboratory for Applied Computational Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Manabe RI; Laboratory for Comprehensive Genomic Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Watanabe T; Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Ozaki K; Laboratory for Comprehensive Genomic Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Kaneko A; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Kajita H; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Fujiki S; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Sato K; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Honma T; Laboratory for Structure-Based Molecular Design, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.
  • Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
  • Fukami T; RIKEN Program for Drug Discovery and Medical Technology Platforms, Yokohama, Japan.
  • Okazaki Y; Laboratory for Comprehensive Genomic Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Ohara O; Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Shultz LD; The Jackson Laboratory, Bar Harbor, ME, USA.
  • Yamada M; High-Dimensional Statistical Modeling Unit, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan.
  • Taniguchi S; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
  • Vyas P; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • de Hoon M; Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Momozawa Y; Department of Haematology, OUH NHS Trust, Oxford, UK.
  • Ishikawa F; Laboratory for Applied Computational Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Nat Cancer ; 2(3): 340-356, 2021 03.
Article em En | MEDLINE | ID: mdl-35121960
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Proteínas Proto-Oncogênicas c-bcl-2 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Proteínas Proto-Oncogênicas c-bcl-2 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão